How Often Should Executives Have a Medical Assessment?
Book Consultation
Dr. Felix Lucian Happich
MD, MHBA
In short
Overview
There is no evidence base for an optimal check up frequency, which is awkward for anyone selling an annual subscription.
Direct Answer
Without chronic conditions: about every three years under 50 and yearly from 50.
Cardiovascular risk separately: every three to five years from age 20, or yearly at borderline risk and above.
Anyone with a chronic condition such as diabetes warrants regular review regardless of age, with or without a general check.
Who This Applies To
Intervals by item
| General review, under 50, no chronic conditions | About every three years |
| General review, 50 and over | Yearly |
| Cardiovascular risk | Every three to five years from 20. Yearly at borderline risk or above |
| Blood pressure | Yearly from 40. Every three to five years from 18 to 39 if normal and no risk factors |
| Alcohol screening | Yearly |
| Breast screening | Every one to two years from 40, by preference |
| Colorectal screening | From 45, interval depending on method |
| Coronary calcium, if it was zero | Three to seven years, and only if it would change a decision |
Option Comparison / Decision Criteria
The first screen picks up everything accumulated over years. Later rounds find only what is new, so fewer cases and a higher proportion of false positives among the positives
Each one then needs chasing
For colorectal and breast screening you need to live 10 years for a 1 in 1000 chance of life extension
A new diagnosis: hypertension, diabetes, kidney disease
Starting a new medication, which needs earlier follow up
Moving into a higher cardiovascular risk band
A new diagnosis in a first degree relative, which can change your screening plan
A new symptom, which is dealt with when it happens rather than at the next slot
Why an In-Person Physician Review Matters
The trend is worth more than the snapshot A blood pressure of 134 means something different rising from 118 than falling from 152.
That is the real argument for regular review, and it works at three year intervals as well as at one. Continuity beats frequency Patients with an established relationship with one clinician have higher rates of appropriate preventive care. More visits to a regular clinician were associated with more colorectal and breast screening, lower incidence and mortality from both, and lower overall mortality. That is an argument for seeing the same doctor, not for seeing one more often. The honest caveat about check ups themselves General health checks did not reduce total, cardiovascular or cancer mortality in a meta analysis of 14 randomised trials covering over 180,000 people. They did improve blood pressure, cholesterol and BMI, especially in higher risk people. So the interval matters less than whether anything is acted on between appointments. When screening should stop Breast and colorectal screening continue while life expectancy is at least 10 years, usually meaning somewhere between 75 and 85. It is worth raising years in advance rather than announcing it, because stopping is easily read as being written off.
Frequently Asked Questions
From 50, yes, and with any chronic condition regardless of age. Below 50 without chronic conditions, about every three years is reasonable. There is no evidence base for an optimal frequency.
No, that is expected. The first round finds everything accumulated over years. Later rounds find only what is new, so fewer cases and a higher share of false positives among the positives.
It also produces more borderline results by chance, each needing chasing. Harm from screening arrives immediately while benefit takes years, so shorter intervals shift that balance the wrong way.
Measurably, yes. An established relationship with one clinician is associated with more appropriate screening, lower incidence and mortality from colorectal and breast cancer, and lower overall mortality.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Cardiovascular diseases
- Cardiovascular disease: risk assessment and reduction
- Hypertension in adults: diagnosis and management
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.